Trevena Inc. (TRVN) |
|
1.47 0 (0%)
|
04-25 16:00 |
|
Open: |
1.45 |
Pre. Close: |
1.47 |
|
High:
|
1.49 |
Low:
|
1.45 |
|
Volume:
|
505,816 |
Market Cap:
|
136M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.492 - 1.5 |
1.5 - 1.508 |
|
Low:
|
1.418 - 1.429 |
1.429 - 1.439 |
|
Close:
|
1.454 - 1.47 |
1.47 - 1.485 |
|
|
|
Technical analysis |
as of: 2019-04-25 4:03:25 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.98  One year: 2.17 |
| Support: |
Support1: 1.43 Support2: 1.19 |
| Resistance: |
Resistance1: 1.69 Resistance2: 1.86 |
| Pivot: |
1.52 |
| Moving Average: |
MA(5): 1.48 MA(20): 1.54
MA(100): 1.13 MA(250): 1.36 |
| MACD: |
MACD(12,26): -0.01 Signal(9): |
| Stochastic oscillator: |
%K(14,3): 19.35 %D(3): 18.85 |
| RSI: |
RSI(14): 45.28 |
| 52-week: |
High: 3.58 Low: 0.38 Change(%): -14.5 |
| Average Vol(K): |
3-Month: 283700 10-Days: 93408 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.TRVN has closed above bottom band by 23.2%. Bollinger Bands are 60.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to TRVN's normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 24 Apr 2019 18:11:53 Z
Trevena (TRVN) to Post Q1 Earnings: What Awaits the Stock?
Mon, 15 Apr 2019 17:09:26 Z
Mallinckrodt (MNK) Completes Enrollment in Skin Tissue Study
Sat, 23 Mar 2019 00:10:14 Z
Trevena (TRVN) Gains As Market Dips: What You Should Know
Wed, 20 Mar 2019 12:07:34 Z
Will Trevena Continue to Surge Higher?
Wed, 20 Mar 2019 00:06:29 Z
Puma Biotech's (PBYI) Nerlynx Gets Approval in Australia
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
92.35 |
| Shares Float (M) |
91.48 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
29.70 |
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.430 |
|
EPS Est. Current Year
|
-1.360 |
|
EPS Est. Next Year
|
-0.930 |
|
EPS Est. Next Quarter
|
-0.320 |
|
Forward EPS
|
-0.809 |
|
Book Value (p.s.)
|
3.450 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-504.75 |
|
Return on Assets (ttm)
|
-45.1 |
|
Return on Equity (ttm)
|
-82.4 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-25.38 |
|
Levered Free Cash Flow (M)
|
-14.71 |
Stock Valuations |
|
P/E
|
-3.44 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
0.43 |
|
P/S
|
1708475008.00 |
|
P/CF
|
-5.39 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
